Mon. 6 May 2024, 4:12pm ET
Benzinga
Earnings, Earnings Beats, News
ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.51) by 27.45 percent. This is a 30.19 percent increase over losses of $(0.53) per share from the same period last year.